We’re honored to be recognized as a Major Contender by Everest Group in their Life Sciences Digital Services PEAK Matrix. In an industry where accelerating innovation, improving patient outcomes, and navigating regulatory complexities are critical, our AI-first approach focuses on delivering digital business outcomes built on a solid data foundation. By working in bite-sized, iterative steps, grounded in deep pharma domain expertise, we help enterprises unlock measurable value through outcomes that are relevant, scalable, and impactful.

“Amid rising R&D costs and regulatory complexities to accelerate product development and market access, life sciences enterprises are increasingly seeking and prioritizing AI-native, domain-centric digital investments that can deliver clear and measurable outcomes across the value chain, which is gaining further momentum with the advent of generative and agentic AI,” said Durga Ambati, Practice Director at Everest Group. “Altimetrik’s innovation-led approach with its CoEs and gen AI-focused labs, combined with strategic partnerships with hyperscalers and data platforms, as well as strong client recognition for its agility and responsiveness, have helped it earn a Major Contender position in Everest Group’s Life Sciences Digital Services PEAK Matrix® Assessment 2025.”